Greystone Associates
 The Power of Insight
    Home   |   About Greystone   |   Products & Services   |   News & Events   |   Contact  

Inhalers and Inhaled Drug Delivery

Contact Sales
Notify Me of Updates
Email This Page
Custom Research
Media Inquiry



Market Knowledge
Biologicals
Cardiology
Disease Therapeutics
Drug Delivery
Immunology
Patient Monitoring
Wound Care



Strategic Planning

Business Development

Technology Management

Delivering Drugs by Inhalation   
Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Much of the interest in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions – aliments that require  .......more

Dry Powder Inhalers
The convergence of socioeconomic and technology factors – the growing emphasis on drug self-administration for chronic conditions, the expected acceleration in protein- and peptide-based therapeutics, the availability of innovative dry powder inhalation devices with unique .......more

Pulmonary Inhalers & Systemic Drug Delivery
Much of the interest in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions – aliments that require frequent drug administration for a protracted period of time. The role of device design and development ,,,,more

Inhaled CNS Therapeutics
Delivering drugs to the central nervous system presents unique challenges. But, drug developers and researchers have discovered that delivering CNS therapeutic drugs via inhalation mitigates several of these issues. The accessibility and vascular structure of the nose make it an attractive route for delivering.........more

Inhaled Pain Management Drugs
Because it has the potential to improve drug therapy compliance, inhaled pain drug delivery addresses a key healthcare issue – one that is particularly problematic in aging populations and developing economies. Several of these ....more